These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26248840)

  • 1. Surgery versus SABR for resectable non-small-cell lung cancer.
    Dearman C; van As N; Crellin A; Slevin N; Sharma RA
    Lancet Oncol; 2015 Aug; 16(8):e373-4. PubMed ID: 26248840
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgery versus SABR for resectable non-small-cell lung cancer.
    Hamaji M; Groth SS; Sugarbaker DJ; Burt BM
    Lancet Oncol; 2015 Aug; 16(8):e372. PubMed ID: 26248839
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgery versus SABR for resectable non-small-cell lung cancer.
    Opitz I; Rocco G; Brunelli A; Varela G; Massard G; Weder W;
    Lancet Oncol; 2015 Aug; 16(8):e372-3. PubMed ID: 26248838
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgery versus SABR for resectable non-small-cell lung cancer.
    Zhang L; Tian J; Wang C
    Lancet Oncol; 2015 Aug; 16(8):e371-2. PubMed ID: 26248837
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgery versus SABR for resectable non-small-cell lung cancer.
    Cao C; D'Amico T; Demmy T; Dunning J; Gossot D; Hansen H; He J; Jheon S; Petersen RH; Sihoe A; Swanson S; Walker W; Yan TD;
    Lancet Oncol; 2015 Aug; 16(8):e370-1. PubMed ID: 26248836
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.
    Chang JY; Senan S; Smit EF; Roth JA
    Lancet Oncol; 2015 Aug; 16(8):e374-5. PubMed ID: 26248841
    [No Abstract]   [Full Text] [Related]  

  • 7. SABR vs surgery for NSCLC in the media.
    Rice D; Sepesi B; Heymach J; Swisher S; Vaporciyan A
    Lancet Oncol; 2015 Sep; 16(9):e422. PubMed ID: 26370343
    [No Abstract]   [Full Text] [Related]  

  • 8. SABR in early operable lung cancer: time for evidence.
    Treasure T; Rintoul RC; Macbeth F
    Lancet Oncol; 2015 Jun; 16(6):597-8. PubMed ID: 25981817
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer.
    Katz MS; Husain ZA
    Lancet Oncol; 2016 Feb; 17(2):e41-e42. PubMed ID: 26868347
    [No Abstract]   [Full Text] [Related]  

  • 10. Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?
    Meyers BF; Puri V; Broderick SR; Samson P; Keogan K; Crabtree TD
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):468-71. PubMed ID: 26259993
    [No Abstract]   [Full Text] [Related]  

  • 11. [Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC--level I evidence at last?].
    Guckenberger M; Andratschke N
    Strahlenther Onkol; 2015 Dec; 191(12):988-90. PubMed ID: 26459463
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' reply.
    Chang JY; Senan S; Smit EF; Roth JA
    Lancet Oncol; 2016 Feb; 17(2):e42-e43. PubMed ID: 26868349
    [No Abstract]   [Full Text] [Related]  

  • 13. Do we know bad science when we see it?
    Jones DR
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):472-3. PubMed ID: 26254751
    [No Abstract]   [Full Text] [Related]  

  • 14. Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit?
    Iyengar P; Lau S; Donington JS; Suh RD
    Am Soc Clin Oncol Educ Book; 2016; 35():e460-7. PubMed ID: 27249754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. If at First You Don't Succeed-Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer.
    Owen D; Siva S; Salama JK; Robinson C; Kruser TJ; Giuliani M
    Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):5-9. PubMed ID: 35964631
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.
    Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY
    Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic ablative radiotherapy versus surgery in older patients with stage I lung cancer.
    Park S; Kim HJ; Park IK; Kim YT; Kang CH
    Eur J Cardiothorac Surg; 2021 Jul; 60(1):74-80. PubMed ID: 33668061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age.
    Seo YS; Kim HJ; Wu HG; Choi SM; Park S
    Thorac Cancer; 2019 Jun; 10(6):1489-1499. PubMed ID: 31124275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?
    Chen H; Louie AV
    Curr Treat Options Oncol; 2016 Jun; 17(6):27. PubMed ID: 27098533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.
    Liu H; Zhang X; Vinogradskiy YY; Swisher SG; Komaki R; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1017-23. PubMed ID: 22543216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.